title: Dapsone interferes with hemoglobin A1c monitoring of diabetes in an HIV-infected patient.
authors.forename: Alison
authors.initials: A
authors.lastname: Roxby
authors.forename: Rupali
authors.initials: R
authors.lastname: Jain
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D002051:Burkitt Lymphoma / Q000188:drug therapy; D018791:CD4 Lymphocyte Count; D002851:Chromatography, High Pressure Liquid; D003622:Dapsone / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy; D004347:Drug Interactions; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D006442:Glycated Hemoglobin / Q000378:metabolism*; D015658:HIV Infections / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016720:Pneumocystis Infections / Q000188:drug therapy*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D001786:Blood Glucose; D003622:Dapsone; D005493:Folic Acid Antagonists; D006442:Glycated Hemoglobin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; C517652:hemoglobin A1c protein, human